Retrieve available abstracts of 52 articles: HTML format
Single Articles
May 2025
JOGI L, Praveen P, Shibu A, Narasimhappa K, et al The Impact of Therapeutic Drug Monitoring on Clozapine Dosing and Clinical
Outcome in a Tertiary Care Center in India: A Retrospective Study.
J Clin Psychopharmacol. 2025;45:251-257. PubMedAbstract available
April 2025
FLANAGAN RJ, Obee SJ, Kim AHM, Every-Palmer S, et al Plasma Clozapine in Treatment Refractory Schizophrenia: What Is the Target Range?
J Clin Psychopharmacol. 2025 Apr 9. doi: 10.1097/JCP.0000000000002007. PubMedAbstract available
COLIJN MA Clozapine Use Among Individuals With Schizophrenia Occurring on the Background of
Intellectual Disability and Rare Genetic Variation: A Retrospective Chart Review.
J Clin Psychopharmacol. 2025 Apr 7. doi: 10.1097/JCP.0000000000002000. PubMedAbstract available
KIKUCHI Y, Sakata M, Ikawa K, Kume D, et al Weekly Changes in the Clozapine Concentration-to-Dose Ratio During Clozapine
Titration in Japanese Patients With Schizophrenia.
J Clin Psychopharmacol. 2025 Apr 7. doi: 10.1097/JCP.0000000000002003. PubMedAbstract available
March 2025
PACILIO RM, Geller JA Persistent Psychosis Associated With Intravenous Ketamine in a Patient Using
Cannabis: A Case Report and Literature Review.
J Clin Psychopharmacol. 2025 Mar 27. doi: 10.1097/JCP.0000000000001995. PubMed
YE CW, Lin CH, Wang SJ Olanzapine-Associated Hyperbilirubinemia in an Adolescent With Autistic Spectrum
Disorder Comorbid With Schizophrenia: A Case Report.
J Clin Psychopharmacol. 2025 Mar 26. doi: 10.1097/JCP.0000000000001974. PubMed
February 2025
DODDI SR, Pham F, Wineke J, Marano C, et al Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man
After COVID-19 Vaccination: A Case Report.
J Clin Psychopharmacol. 2025 Feb 10. doi: 10.1097/JCP.0000000000001969. PubMed
ELOMA-ATA A, Wafy F, Parikh A, Tusher A, et al A Case of Hypothermia Associated With the Use of Multiple Antipsychotics in a
Patient With Late-Onset Schizophrenia.
J Clin Psychopharmacol. 2025 Feb 7. doi: 10.1097/JCP.0000000000001961. PubMed
GOFF DC At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The
Combination of Xanomeline and Trospium (Cobenfy).
J Clin Psychopharmacol. 2025 Feb 6. doi: 10.1097/JCP.0000000000001959. PubMed
January 2025
FLANAGAN RJ, Obee SJ, Kim AHM, Every-Palmer S, et al Clozapine Dosage in Treatment-Refractory Schizophrenia: A Reply to Dr Grover and
Colleagues.
J Clin Psychopharmacol. 2025 Jan 14. doi: 10.1097/JCP.0000000000001955. PubMed
OLMOS I, Ricciardi C, Mato M, Guevara N, et al Optimization of Clozapine Treatment: Study of Variables Affecting Response in
Uruguayan Patients With Schizophrenia.
J Clin Psychopharmacol. 2025;45:20-27. PubMedAbstract available
December 2024
EL JABIRY SE, Benkarroum F, Barrimi M, Elghazouani F, et al Risperidone-Associated Stuttering in Patient With Schizophrenia: A Case Report.
J Clin Psychopharmacol. 2024 Dec 31. doi: 10.1097/JCP.0000000000001950. PubMed
HOOBERMAN AJ, Martinez NJ, Stojcevski M, Wechsler B, et al A Case of Tacrolimus-Associated Psychosis.
J Clin Psychopharmacol. 2024 Dec 31. doi: 10.1097/JCP.0000000000001956. PubMed
BUESKING SC, Kriz CR, Jarvis SP, Nelson LA, et al Recognition of Clozapine-Associated Eosinopenia in Patients With
Treatment-Resistant Schizophrenia: A Report of 3 Cases and Literature Review.
J Clin Psychopharmacol. 2024 Dec 17. doi: 10.1097/JCP.0000000000001947. PubMed
TAKEUCHI H, Uchida H Efficacy and Safety of Dose Increase From 40 mg/d to 80 mg/d of Lurasidone in
Patients With Schizophrenia: A Post Hoc Analysis of Extension Trial.
J Clin Psychopharmacol. 2024 Dec 2. doi: 10.1097/JCP.0000000000001943. PubMedAbstract available
November 2024
O'CONNELL P, Alsaffar M The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for
Treatment-Resistant Schizophrenia: The Role of Pseudoephedrine.
J Clin Psychopharmacol. 2024 Nov 12. doi: 10.1097/JCP.0000000000001930. PubMed
FLANAGAN RJ, Obee SJ, Kim AHM, Every-Palmer S, et al Effect of Valproate Coprescription on Clozapine Pharmacokinetics in Clinical
Practice.
J Clin Psychopharmacol. 2024;44:561-569. PubMedAbstract available
GURCAN G, Atalay B, Deveci E Clozapine-Associated Sialorrhea: A Literature Review.
J Clin Psychopharmacol. 2024;44:570-575. PubMedAbstract available
LOCHMANN VAN BENNEKOM MWH, Gijsman HJ, IntHout J, Verkes RJ, et al Antipsychotic Polypharmacy in Time Course: Evidence for a Cross-titration Trap.
J Clin Psychopharmacol. 2024;44:545-550. PubMedAbstract available
October 2024
PEREZ-SAGASETA DE ILURDOZ I, Aparicio-Dominguez A, Yelmo-Cruz S, Cardenes-Moreno C, et al alpha-PVP Associated Psychosis: A Case Report.
J Clin Psychopharmacol. 2024 Oct 11. doi: 10.1097/JCP.0000000000001918. PubMed
September 2024
MITOMA R, Hirano S, Nakao T Successful Management of ECT-Resistant Interictal Psychosis With Clozapine: A
Case Report.
J Clin Psychopharmacol. 2024;44:527-528. PubMed
DI LISI A, Pupo S, Menchetti M, Pelizza L, et al Antipsychotic Treatment in People at Clinical High Risk for Psychosis: A
Narrative Review of Suggestions for Clinical Practice.
J Clin Psychopharmacol. 2024;44:502-508. PubMedAbstract available
FLANAGAN RJ, Obee SJ, Kim AHM, Every-Palmer S, et al Plasma Clozapine and N -Desmethylclozapine (Norclozapine) Concentrations and the
Clozapine/Norclozapine Ratio : Effect of Dose, Sex, and Cigarette Smoking.
J Clin Psychopharmacol. 2024;44:492-501. PubMedAbstract available
August 2024
BUCHANAN RW, Werkheiser AE, Michel H, Zaranski J, et al Prebiotic Treatment in People With Schizophrenia.
J Clin Psychopharmacol. 2024 Aug 16. doi: 10.1097/JCP.0000000000001899. PubMedAbstract available
July 2024
HAUSER RA, Barkay H, Fernandez HH, Jimenez-Shahed J, et al Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of
Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of
the 3-Year, Open-Label Extension Study.
J Clin Psychopharmacol. 2024;44:386-396. PubMedAbstract available
GOUDA M, Abe M, Watanabe Y, Kato TA, et al Analysis of Antipsychotic Dosage in Patients With Tardive Dyskinesia: A
Case-Control Study Using the Claims Database of the Corporate Health Insurance
Association.
J Clin Psychopharmacol. 2024;44:378-385. PubMedAbstract available
PACILIO RM, Dalack GW Asthma and Atypical Antipsychotics: A Systematic Literature Review and Case
Report of Respiratory Side Effects With Lurasidone, Cariprazine, and
Lumateperone.
J Clin Psychopharmacol. 2024;44:436-437. PubMed
May 2024
KARAL BN, Ozdemir YE, Karayagmurlu A The Management of Very Early-Onset Schizophrenia With an Olanzapine and
Amisulpride Combination.
J Clin Psychopharmacol. 2024 May 2. doi: 10.1097/JCP.0000000000001853. PubMed
OKADA Y, Inada K, Akazawa M Comparative Effectiveness of Long-Acting Injectable Versus Oral Antipsychotics in
Patients With Schizophrenia Using the Prevalent New User Design and Subgroup
Analyses.
J Clin Psychopharmacol. 2024;44:263-271. PubMedAbstract available
DE LEON J Can Slow Personalized Titration Using C-Reactive Protein Monitoring Decrease the
High Rates and Mortality of Clozapine-Associated Myocarditis Seen in Some
Countries? A Call for Research.
J Clin Psychopharmacol. 2024;44:212-219. PubMedAbstract available
April 2024
SCALA M, Martinez Trapote P, Rodriguez-Jimenez R, Pecorino B, et al Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal
Twist in a Female Patient: A Case Report of a Progestin-Only Pill.
J Clin Psychopharmacol. 2024 Apr 9. doi: 10.1097/JCP.0000000000001836. PubMed
March 2024
KORKMAZ SA, Koca E, Yilmaz O, Ozbek T, et al Real-World Evidence of Antipsychotic Monotherapy Versus Polypharmacy in the
Treatment of Schizophrenia Spectrum Disorders.
J Clin Psychopharmacol. 2024 Mar 5. doi: 10.1097/JCP.0000000000001837. PubMedAbstract available
NAGANO M, Susuta Y, Masui H, Watanabe Y, et al Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia
and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive
Disorder: Primary Results and Post Hoc Analyses of the J-KINECT Study.
J Clin Psychopharmacol. 2024;44:107-116. PubMedAbstract available
February 2024
MORI Y, Watanabe K, Suzuki Y, Ono H, et al Clozapine-Associated Myocarditis in a Patient With Schizophrenia Taking
Lemborexant: A Case Report.
J Clin Psychopharmacol. 2024 Feb 8. doi: 10.1097/JCP.0000000000001817. PubMed
DIMA A, Abdelsamie A, Clark-Castillo R, Webb-Wilson H, et al Overcoming Obstacles to Clozapine Treatment: A Case of Clozapine Rechallenge in
ECT-Resistant Schizophrenia With Catatonic Features.
J Clin Psychopharmacol. 2024 Feb 5. doi: 10.1097/JCP.0000000000001819. PubMed
January 2024
WATANABE M, Misawa F, Takeuchi H Real-World Effectiveness of High-Dose Olanzapine and Clozapine for
Treatment-Resistant Schizophrenia in Japan: A Retrospective Bidirectional
Mirror-Image Study.
J Clin Psychopharmacol. 2024 Jan 26. doi: 10.1097/JCP.0000000000001804. PubMedAbstract available
KJELBY E, Gjestad R, Fathian F, Sinkeviciute I, et al Reply to a Letter to the Editors From Dr de Souza and colleagues: "Unraveling the
Optimal Treatment Approach for Depression in Schizophrenia Spectrum: A Quest for
Clarity".
J Clin Psychopharmacol. 2024;44:76-78. PubMed
DE SOUZA JUNIOR SA, Cavalcante da Rocha ME, Marques Andrade AG, Fernandes de Moraes CL, et al Unraveling the Optimal Treatment Approach for Depression in Schizophrenia
Spectrum: A Quest for Clarity.
J Clin Psychopharmacol. 2024;44:74-76. PubMed
MOHAMMAD-GHOLIZAD F, Karimzadeh I, Moghimi-Sarani E, Arshadi M, et al Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium
Bromide Nasal Spray, and Amitriptyline Tablet in the Management of
Clozapine-Associated Sialorrhea in Patients With Refractory Schizophrenia: A
Randomized Clinical Trial
J Clin Psychopharmacol. 2024;44:9-15. PubMedAbstract available
KARACAM DOGAN M, Yildiz FG, Temucin CM, Ertugrul A, et al Effects of Clozapine on Cortical Inhibition: A Transcranial Magnetic Stimulation
Follow-up Study.
J Clin Psychopharmacol. 2024;44:16-24. PubMedAbstract available
November 2023
LEE MA, Cola P, Jayathilake K, Meltzer HY, et al Reply to Dr Yucel's Comments on the Article "Long-term Outcome of Clozapine in
Treatment-Resistant Schizophrenia".
J Clin Psychopharmacol. 2023;43:555-556. PubMed
YUCEL A Critical Feedback on Article by Lee and Colleagues: "Long-Term Outcome of
Clozapine in Treatment-Resistant Schizophrenia".
J Clin Psychopharmacol. 2023;43:555. PubMed
KINDT H, Mahgoub Y Should We Be Prescribing Stimulants to Patients With Multiple Sclerosis?: A Case
Report of Stimulant-Associated Psychosis.
J Clin Psychopharmacol. 2023;43:551-553. PubMed
MAGISTRI C, Mellini C Clozapine-Associated Agranulocytosis: A Systematic Review. Is It Really So
Frighteningly Common?
J Clin Psychopharmacol. 2023;43:527-533. PubMedAbstract available
CONATY O, Doherty AM, Lally J Severe Alprazolam Withdrawal With Delirium and Psychosis: A Case Report and
Literature Review.
J Clin Psychopharmacol. 2023;43:511-513. PubMedAbstract available
September 2023
KINDT H, Mahgoub Y Should We Be Prescribing Stimulants to Patients With Multiple Sclerosis? A Case
Report of Stimulant-Associated Psychosis.
J Clin Psychopharmacol. 2023 Sep 29. doi: 10.1097/JCP.0000000000001766. PubMed
CONATY O, Doherty AM, Lally J Severe Alprazolam Withdrawal With Delirium and Psychosis. A Case Report and
Literature Review.
J Clin Psychopharmacol. 2023 Sep 7. doi: 10.1097/JCP.0000000000001758. PubMedAbstract available
TKACH N, Opler DJ A Consideration for the Study of the Use of Cyproheptadine in Parkinson Disease
Psychosis.
J Clin Psychopharmacol. 2023;43:481-482. PubMed
DE LIMA DN JR, Frota IJ, Macedo DS, Sanders LLO, et al Alpha Lipoic Acid for Schizophrenia: Future Investigations With Low Doses and
Treatment-Resistant Patients-Reply to Letter by Kishi and Colleagues.
J Clin Psychopharmacol. 2023;43:478-479. PubMed
KISHI T, Sakuma K, Miura G, Ito Y, et al Alpha Lipoic Acid for Schizophrenia: A Systematic Review and Meta-analysis.
J Clin Psychopharmacol. 2023;43:477-478. PubMed
BROTHWOOD PL, Husain M, Pinson J, Oloyede E, et al Clozapine in Combination With Olanzapine Long-Acting Injection: The Intersection
of Treatment-Resistant Schizophrenia and Poor Medication Adherence-A Case Report.
J Clin Psychopharmacol. 2023;43:472-474. PubMed
JOGI L, Subu O, Jaishankar P, Kumar V, et al Management of Treatment-Resistant Schizophrenia in a Patient With Epilepsy With
Add on Low-Dose Clozapine-A Case Report.
J Clin Psychopharmacol. 2023;43:468-469. PubMed